QGEN QIAGEN N.V.

Stock NYSE Healthcare

US$50.22 -0.28% Latest close

Trend channel, buy level and 3-month target. Information only, not financial advice.

Above the channel ยท 9-month channel rising

Closed above resistance (US$48.25). The fitted trend may no longer apply.

9-month channel
US$43.97 โ€“ US$48.25 ยท rising, +14% a year
Price in channel
146% (0% = floor, 100% = ceiling)
Ceiling overhead
none โ€” above both ceilings
Turns bearish below
US$43.97
Published levels
Buy and target are not from this channel โ€” see below.

What broke this trend

The fall
-41% from US$55.1821 Jan 2026 โ†’ 11 May 2026
Whose problem it was
This company0 of 1 Biological Products, (No Diagnostic Substances) peers fell with it
Does it resolve?
Temporary falls like it have resolved on the record
Regained so far
79%of what it lost
What the record says
77% of 938 comparable falls came back, typically in 86 days measured across every stock we hold history for, its peer group being too small

Fell -41% (21 Jan 2026 โ†’ 11 May 2026); regained 79% so far; company-specific.

Buy and target use the recovery path, not the channel.

Reported at the time: Qiagen Explores Possible Sale After New Buyer Talks: Report โ€” 21 Jan 2026

Price history, with the path projected 3 months forward

Updated 5:37 AM ET (78 h ago)

US$30.0US$40.0US$50.0Nov 23Apr 24Sept 24Feb 25July 25Dec 25May 26Oct 26 today Buy nowTarget Buy now US$50.3 ยท est. 29 Oct 26Our target US$55.9 ยท est. 27 Jan 27
  • Daily close
  • Upper trend line (9 months)
  • Lower trend line (9 months)
  • Dashed after today: projected 3 months
  • Our buy
  • Our target

Suggested path

Buy now

US$50.22

last close ยท 30 Oct 2026

Our target

US$55.92

by 30 Jan 2027

Projected move

11.3%

gross, before costs

Last close is our buy.

Target: recovery of the recent fall.

This move size: reached in 33% of 21 past stretches, typically in 90 days. (0.12% per day)

Upper line touches
3
Lower line touches
2
Fit confidence
60%
Fitted
1 Nov 2026

Company information

About QIAGEN N.V.

QIAGEN N.V. is a US-listed company, classified under Biological Products, (No Diagnostic Substances), with principal offices in PL VENLO.

Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Country
United States

Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.